Tapewire

Nasdaq · USD

BYFC

BROADWAY FINANCIAL CORP DE

Export transactions ↓
Tapewire entity
6703
SEC CIK
0001001171
Parsed reports
195

Last 12 months

Inside the activity.

0 purchase rows · 22 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 2026022
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 28, 2026 Filed Jul 30, 2026 18:46 UTC
Carew TinaEVP, CLO & Corporate Secretary
GrantCommon Stock 4,921 $10.16 $49,997.36
Disclosure

SEC source: 0001140361-26-030227 · form4.xml · nonDerivative · entry 1

Carew Tina · CIK 0002141683 · EVP, CLO & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,921

F1 · shares: Restricted Stock granted March 02, 2026 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

Read SEC document
July 28, 2026 Filed Jul 31, 2026 21:06 UTC Amendment
Carew TinaEVP, CLO & Corporate Secretary
GrantCommon Stock 4,921 $10.16 $49,997.36
Disclosure

SEC source: 0001140361-26-030526 · form4.xml · nonDerivative · entry 1

Carew Tina · CIK 0002141683 · EVP, CLO & Corporate Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,921

F1 · shares: This amendment is being filed to update the grant date in this Note 1 to the Form 4 due to a clerical error. Restricted Stock granted July 28, 2026 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

Read SEC document
May 26, 2026 Filed May 27, 2026 21:39 UTC SaleCommon Stock 1 $9.68 $9.68
Disclosure

SEC source: 0001140361-26-023021 · form4.xml · nonDerivative · entry 14

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,359

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 26, 2026 Filed May 27, 2026 21:39 UTC SaleCommon Stock 263 $9.57 $2,516.91
Disclosure

SEC source: 0001140361-26-023021 · form4.xml · nonDerivative · entry 13

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,360

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 26, 2026 Filed May 27, 2026 21:39 UTC SaleCommon Stock 5 $9.54 $47.68
Disclosure

SEC source: 0001140361-26-023021 · form4.xml · nonDerivative · entry 12

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,623

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 26, 2026 Filed May 27, 2026 21:39 UTC SaleCommon Stock 1 $9.53 $9.53
Disclosure

SEC source: 0001140361-26-023021 · form4.xml · nonDerivative · entry 11

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,628

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 26, 2026 Filed May 27, 2026 21:39 UTC SaleCommon Stock 202 $9.50 $1,919.00
Disclosure

SEC source: 0001140361-26-023021 · form4.xml · nonDerivative · entry 10

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,629

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 26, 2026 Filed May 27, 2026 21:39 UTC SaleCommon Stock 5 $9.47 $47.33
Disclosure

SEC source: 0001140361-26-023021 · form4.xml · nonDerivative · entry 9

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,831

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 26, 2026 Filed May 27, 2026 21:39 UTC SaleCommon Stock 100 $9.46 $946.11
Disclosure

SEC source: 0001140361-26-023021 · form4.xml · nonDerivative · entry 8

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,836

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 26, 2026 Filed May 27, 2026 21:39 UTC SaleCommon Stock 2,353 $9.46 $22,259.38
Disclosure

SEC source: 0001140361-26-023021 · form4.xml · nonDerivative · entry 7

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,936

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 26, 2026 Filed May 27, 2026 21:39 UTC SaleCommon Stock 2 $9.41 $18.82
Disclosure

SEC source: 0001140361-26-023021 · form4.xml · nonDerivative · entry 6

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,289

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 26, 2026 Filed May 27, 2026 21:39 UTC SaleCommon Stock 574 $9.40 $5,395.66
Disclosure

SEC source: 0001140361-26-023021 · form4.xml · nonDerivative · entry 5

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,291

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 26, 2026 Filed May 27, 2026 21:39 UTC SaleCommon Stock 4,887 $9.40 $45,937.80
Disclosure

SEC source: 0001140361-26-023021 · form4.xml · nonDerivative · entry 4

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,865

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 26, 2026 Filed May 27, 2026 21:39 UTC SaleCommon Stock 107 $9.39 $1,004.20
Disclosure

SEC source: 0001140361-26-023021 · form4.xml · nonDerivative · entry 3

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,752

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 26, 2026 Filed May 27, 2026 21:39 UTC SaleCommon Stock 3 $9.37 $28.11
Disclosure

SEC source: 0001140361-26-023021 · form4.xml · nonDerivative · entry 2

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,859

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 26, 2026 Filed May 27, 2026 21:39 UTC SaleCommon Stock 97 $9.36 $907.92
Disclosure

SEC source: 0001140361-26-023021 · form4.xml · nonDerivative · entry 1

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,862

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 22, 2026 Filed May 27, 2026 21:34 UTC SaleCommon Stock 200 $9.60 $1,920.92
Disclosure

SEC source: 0001140361-26-023017 · form4.xml · nonDerivative · entry 7

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,959

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 22, 2026 Filed May 27, 2026 21:34 UTC SaleCommon Stock 2 $9.59 $19.18
Disclosure

SEC source: 0001140361-26-023017 · form4.xml · nonDerivative · entry 6

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,159

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 22, 2026 Filed May 27, 2026 21:34 UTC SaleCommon Stock 568 $9.58 $5,441.44
Disclosure

SEC source: 0001140361-26-023017 · form4.xml · nonDerivative · entry 5

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,161

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 22, 2026 Filed May 27, 2026 21:34 UTC SaleCommon Stock 30 $9.59 $287.84
Disclosure

SEC source: 0001140361-26-023017 · form4.xml · nonDerivative · entry 4

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,729

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 22, 2026 Filed May 27, 2026 21:34 UTC SaleCommon Stock 300 $9.51 $2,853.00
Disclosure

SEC source: 0001140361-26-023017 · form4.xml · nonDerivative · entry 3

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,759

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 22, 2026 Filed May 27, 2026 21:34 UTC SaleCommon Stock 200 $9.56 $1,912.00
Disclosure

SEC source: 0001140361-26-023017 · form4.xml · nonDerivative · entry 2

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,059

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 22, 2026 Filed May 27, 2026 21:34 UTC SaleCommon Stock 100 $9.69 $969.00
Disclosure

SEC source: 0001140361-26-023017 · form4.xml · nonDerivative · entry 1

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,259

F1 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
May 07, 2026 Filed May 14, 2026 22:28 UTC
Driver JohnDirector
SaleCommon Stock 6,500 $9.36 $60,846.50
Disclosure

SEC source: 0001140361-26-021383 · form4.xml · nonDerivative · entry 1

Driver John · CIK 0001930914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,711

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:31 UTC GrantCommon Stock 2,675 $7.85 $20,998.75
Disclosure

SEC source: 0001140361-26-007888 · form4.xml · nonDerivative · entry 1

JOHNS MARIE C · CIK 0001108201 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,223

F1 · shares: Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:31 UTC
Washington LaShanya DemetriceEVP, Chief Credit Officer
GrantCommon Stock 6,480 $7.85 $50,868.00
Disclosure

SEC source: 0001140361-26-007889 · form4.xml · nonDerivative · entry 1

Washington LaShanya Demetrice · CIK 0001970473 · EVP, Chief Credit Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,300

F1 · shares: Restricted Stock granted March 02, 2026 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

F2 · balance_after: Shares Amount adjusted for Reverse Stock split effective October 31, 2023.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:30 UTC GrantCommon Stock 2,675 $7.85 $20,998.75
Disclosure

SEC source: 0001140361-26-007885 · form4.xml · nonDerivative · entry 1

McGrady David J. · CIK 0001851527 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,223

F1 · shares: Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:28 UTC
Argrett Brian EDirector · President/CEO
GrantCommon Stock 23,793 $7.85 $186,775.05
Disclosure

SEC source: 0001140361-26-007882 · form4.xml · nonDerivative · entry 1

Argrett Brian E · CIK 0001361104 · Director · President/CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,752

F1 · shares: Restricted Stock granted March 02, 2026, which shall vest as follows: to the extent of thirty-three percent (33%) of the shares covered thereby on the first anniversary of the date of grant, with the balance vesting ratably over the succeeding twenty-four (24) months.

F2 · balance_after: Shares amount adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:24 UTC GrantCommon Stock 2,675 $7.85 $20,998.75
Disclosure

SEC source: 0001140361-26-007879 · form4.xml · nonDerivative · entry 1

Bradshaw Wayne-Kent A. · CIK 0001456220 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,359

F1 · shares: Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023. Further, the amount includes 5,216 shares allocated under the 'ESOP'.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:23 UTC
Jennings William JustinEVP, Chief Deposit Officer
GrantCommon Stock 4,458 $7.85 $34,995.30
Disclosure

SEC source: 0001140361-26-007877 · form4.xml · nonDerivative · entry 1

Jennings William Justin · CIK 0001905618 · EVP, Chief Deposit Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,394

F1 · shares: Restricted Stock granted March 02, 2026 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:20 UTC
Hentges MaryDirector
GrantCommon Stock 2,675 $7.85 $20,998.75
Disclosure

SEC source: 0001140361-26-007875 · form4.xml · nonDerivative · entry 1

Hentges Mary · CIK 0001829575 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,675

F1 · shares: Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:11 UTC GrantCommon Stock 2,675 $7.85 $20,998.75
Disclosure

SEC source: 0001140361-26-007864 · form4.xml · nonDerivative · entry 1

DAVIDSON ROBERT C JR · CIK 0001219803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,127

F1 · shares: Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 21:15 UTC
Allen John AnthonyEVP, Chief Banking Officer
GrantCommon Stock 7,833 $7.85 $61,489.05
Disclosure

SEC source: 0001140361-26-007867 · form4.xml · nonDerivative · entry 1

Allen John Anthony · CIK 0002055456 · EVP, Chief Banking Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,016

F1 · shares: Restricted Stock granted March 02, 2026 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 19:14 UTC
Ibrahim ZackEVP/Chief Financial Officer
GrantCommon Stock 11,521 $7.85 $90,439.85
Disclosure

SEC source: 0001140361-26-007832 · form4.xml · nonDerivative · entry 1

Ibrahim Zack · CIK 0002024462 · EVP/Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,267

F1 · shares: Restricted Stock granted March 02, 2026 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

Read SEC document
March 02, 2026 Filed Mar 4, 2026 19:03 UTC GrantCommon Stock 2,675 $7.85 $20,998.75
Disclosure

SEC source: 0001140361-26-007821 · form4.xml · nonDerivative · entry 1

Ross Dutch C. III · CIK 0001668417 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,062

F1 · shares: Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 02, 2026 Filed Mar 5, 2026 13:40 UTC GrantCommon Stock 2,675 $7.85 $20,998.75
Disclosure

SEC source: 0001140361-26-007999 · form4.xml · nonDerivative · entry 1

Donovan Mary Ann · CIK 0001851769 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,223

F1 · shares: Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the Amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
March 02, 2026 Filed Mar 7, 2026 02:29 UTC
Driver JohnDirector
GrantCommon Stock 2,675 $7.85 $20,998.75
Disclosure

SEC source: 0001140361-26-008313 · form4.xml · nonDerivative · entry 1

Driver John · CIK 0001930914 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,211

F1 · shares: Represents Award of Unrestricted stock issued on March 02, 2026 pursuant to the amended and Restated 2018 Long Term Incentive Plan of Broadway Financial Corporation.

F2 · balance_after: The amount of securities adjusted for reverse stock split effective October 31, 2023.

Read SEC document
October 15, 2025 Filed Nov 21, 2025 18:52 UTC SaleCommon Stock 1,000 $7.10 $7,098.70
Disclosure

SEC source: 0001140361-25-042948 · form4.xml · nonDerivative · entry 10

DAVIDSON ROBERT C JR · CIK 0001219803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,452

F1 · shares: The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing.

Read SEC document
October 14, 2025 Filed Oct 23, 2025 19:31 UTC
Jennings William JustinEVP, Chief Deposit Officer
GrantCommon Stock 4,936 $7.09 $34,996.24
Disclosure

SEC source: 0001140361-25-039071 · form4.xml · nonDerivative · entry 1

Jennings William Justin · CIK 0001905618 · EVP, Chief Deposit Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,936

F1 · shares: Restricted Stock granted October 14, 2025 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

Read SEC document
October 14, 2025 Filed Nov 21, 2025 18:52 UTC SaleCommon Stock 1,000 $7.21 $7,210.00
Disclosure

SEC source: 0001140361-25-042948 · form4.xml · nonDerivative · entry 9

DAVIDSON ROBERT C JR · CIK 0001219803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,452

F1 · shares: The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing.

Read SEC document
October 13, 2025 Filed Nov 21, 2025 18:52 UTC SaleCommon Stock 1,000 $7.32 $7,324.90
Disclosure

SEC source: 0001140361-25-042948 · form4.xml · nonDerivative · entry 8

DAVIDSON ROBERT C JR · CIK 0001219803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,452

F1 · shares: The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing.

Read SEC document
October 10, 2025 Filed Nov 21, 2025 18:52 UTC SaleCommon Stock 1,000 $7.39 $7,390.00
Disclosure

SEC source: 0001140361-25-042948 · form4.xml · nonDerivative · entry 7

DAVIDSON ROBERT C JR · CIK 0001219803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,452

F1 · shares: The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing.

Read SEC document
October 09, 2025 Filed Nov 21, 2025 18:52 UTC SaleCommon Stock 1,000 $7.61 $7,610.00
Disclosure

SEC source: 0001140361-25-042948 · form4.xml · nonDerivative · entry 6

DAVIDSON ROBERT C JR · CIK 0001219803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,452

F1 · shares: The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing.

Read SEC document
October 08, 2025 Filed Nov 21, 2025 18:52 UTC SaleCommon Stock 1,000 $7.70 $7,700.00
Disclosure

SEC source: 0001140361-25-042948 · form4.xml · nonDerivative · entry 5

DAVIDSON ROBERT C JR · CIK 0001219803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,452

F1 · shares: The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing.

Read SEC document
October 07, 2025 Filed Nov 21, 2025 18:52 UTC SaleCommon Stock 1,000 $7.61 $7,610.00
Disclosure

SEC source: 0001140361-25-042948 · form4.xml · nonDerivative · entry 4

DAVIDSON ROBERT C JR · CIK 0001219803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,452

F1 · shares: The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing.

Read SEC document
October 06, 2025 Filed Nov 21, 2025 18:52 UTC SaleCommon Stock 1,000 $7.70 $7,700.00
Disclosure

SEC source: 0001140361-25-042948 · form4.xml · nonDerivative · entry 3

DAVIDSON ROBERT C JR · CIK 0001219803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,452

F1 · shares: The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing.

Read SEC document
October 03, 2025 Filed Nov 21, 2025 18:52 UTC SaleCommon Stock 1,000 $7.50 $7,500.00
Disclosure

SEC source: 0001140361-25-042948 · form4.xml · nonDerivative · entry 2

DAVIDSON ROBERT C JR · CIK 0001219803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,452

F1 · shares: The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing.

Read SEC document
October 02, 2025 Filed Nov 21, 2025 18:52 UTC SaleCommon Stock 1,000 $7.20 $7,200.00
Disclosure

SEC source: 0001140361-25-042948 · form4.xml · nonDerivative · entry 1

DAVIDSON ROBERT C JR · CIK 0001219803 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,452

F1 · shares: The shares reported on this Form 4 were sold by the Reporting Person's broker in connection with ordinary course portfolio rebalancing.

Read SEC document
May 28, 2025 Filed May 30, 2025 01:39 UTC
Allen John AnthonyEVP, Chief Banking Officer
GrantCommon Stock 8,183 $6.11 $49,998.13
Disclosure

SEC source: 0001140361-25-020832 · form4.xml · nonDerivative · entry 1

Allen John Anthony · CIK 0002055456 · EVP, Chief Banking Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,183

F1 · shares: Restricted Stock granted May 28, 2025 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

Read SEC document
March 24, 2025 Filed Mar 26, 2025 22:50 UTC
Sur Elizabeth FarrellyEVP, Chief Risk Officer
GrantCommon Stock 4,368 $7.23 $31,580.64
Disclosure

SEC source: 0001140361-25-010509 · form4.xml · nonDerivative · entry 1

Sur Elizabeth Farrelly · CIK 0002024356 · EVP, Chief Risk Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,368

F1 · shares: Restricted Stock granted March 24, 2025 with a 4 year vesting in accordance with the Broadway Financial Corporation Amended and Restated 2018 Long-Term Incentive Plan effective April 16, 2023.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.